Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production

Blood

Volumn 92, Issue 5, 1998, Pages 1793-1798

  Corazza, Francis ^a   Beguin, Yves ^b   Bergmann, Pierre ^b   André, Marie ^b   Ferster, Alina ^b   Devalck, Christine ^b   Fondu, Pierre ^b   Buyse, Marc ^b   Sariban, Eric ^b  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ANEMIA; ARTICLE; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; DISEASE ASSOCIATION; ERYTHROPOIESIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0032170572     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.5.1793.417k23_1793_1798     Document Type: Article

References (33)

1. Beguin Y, Clemons G, Pootrakul P, Fillet G: Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 81:1067, 1993
2. Hellebostad M, Marstrander J, Slrdhl SH, Cotes M, Refsum HE: Serum immunoreactive erythropoietin in children with acute leukemia at various stages of disease and the effects of treatment. Eur J Haematol 44:159, 1990
3. Pohl C, Schobert I, Moter A, Woll EM, Schwonzen M, Hiersche A, Diehl V: Serum erythropoietin JeveJs in patients with Hodgkin's lymphoma at the time of diagnosis. Ann Oncol 3:172, 1992
4. Beguin Y, Lampertz S, Fillet G: Serum erythropoietin in chronic lymphocytic leukemia. Br J Hematol 93:154, 1996
5. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL: Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689, 1990
6. Nathan DG, Orkin SH: Nathan and Oski's Hematology of Infancy and Childhood (ed 5). Philadelphia, PA, Saunders, 1998, Appendix 11
7. Erslev AJ, Wilson J, Caro J: Erythropoietin titers in anemic, non uremie patients. J Lab Clin Med 109:429, 1987
8. Schrezenmeier H, Noé G, Raghavachar A, Rich IN, Heimpel H, Kubanek B: Serum erythropoietin and serum transferrin receptor levels in aplastic anemia. Br J Hematol 88:286, 1994
9. Punnonen K, Irjala K, Rajamaki A: Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem 40:774, 1994
10. André M, Ferster A, Toppet M, Fondu P, Dratwa M, Bergmann P: Performance of an immunoradiometric assay of erythropoietin and results for specimens from anemic and polycythemic patients. Clin Chem 38:758, 1992
11. Wood PA, Hrushesky WJM: Cisplatin-associated anemia: An erythropoietin deficiency syndrome. J Clin Invest 95:1650, 1995
12. Smith DH, Goldwasser E, Vokes EE: Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy. Cancer 68:1101, 1991
13. Urabe A, Mitani K, Yoshinaga K, Iki S, Yagisawa M, Ohbayashi Y, Takaku F: Serum erythropoietin titers in hematological malignancies and related diseases, Int J Cell Cloning 10:333, 1992
14. Beguin Y, Yerna M, Loo M, Weber M, Fillet G: Erythropoiesis in multiple myeloma: Defective red cell production due to inappropriate erythropoietin production. Br J Haematol 82:648, 1992
15. Rodriguez-Cimadevilla JC, Beauchemin V, Villeneuve L, Letendre F, Shaw A, Hoang T: Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: Role of interleukin-1 as an endogenous inducer. Blood 76:1481, 1990
16. Balkwill F, Osborne R, Burke F, Naylor S, Talbot D, Durbin H, Tavernier J, Fiers-W: Evidence for tumor necrosis factor/cachectin production in cancer. Lancet 2;1229, 1987
17. Naumovski L, Utz PJ, Bergstrom SK, Morgan R, Molina A, Toole JJ, Glader BE, McFall P, Weiss LM, Warnke R, Smith SD: SUP-HD1: A new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma. Blood 74:2733, 1989
18. Kremer JP, Reisbach G, Nerl C, Dormer P: B-cell chronic lymphocytic leukemia cells express and release transforming growth factor-beta. Br J Haematol 80:480 1992
19. Means RT: Pathogenesis of the anemia of chronic disease: A cytokine-mediated anemia. Stem Cells 13:32, 1995
20. Jelkmann W, Pagel H, Wolff M, Fandrey J: Monokines inhibiting erythropoietin production in human hepatoma cultures and isolated perfused rat kidneys. Life Sci 50:301, 1991
21. Faquin WC, Schneider TJ, Goldberg MA: Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79: 1987, 1992
22. Rusten LS, Jacobsen SEW: Tumor necrosis factor (TNF)-α directly inhibits human erythropoiesis in vitro: Role of p55 and p75 TNF receptors. Blood 85:989, 1995
23. Johnson CS, Keckler DJ, Topper MI, Braunschweiger PG, Furmanski P: In vivo hematopoietic effect of recombinant interleukin-1α in mice: Stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors; suppression of late stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood 73:678, 1989
24. Mamus SW, Beck-Schroeder SK, Zanjani ED: Suppression of normal human erythropoiesis by gamma interferon in vitro: Role of monocytes and T-lymphocytes. J Clin Invest 75:1496, 1985
25. Miller KL, Carlino JA, Ogawa Y, Avis PD, Carroll KG: Alterations in erythropoiesis in TGF-beta 1-treated mice. Exp Hematol 20:951, 1992
26. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann R, Cerami A, Ralph P: Comparative analysis of the suppressive effects of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of myeloid progenitor cells. J Immunol 150:3448, 1993
27. Cooper S, Mantel C, Broxmeyer HE: Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-la. Exp Hematol 22:186, 1994
28. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S: Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15:1218, 1997
29. Cascinu S, Fedeli A, Del Ferro E, Luzi Fedeli S, Catalano G: Recombinant human erythropoietin treatment in cisplatin-associated anemia: A randomized, double-blind trial with placebo. J Clin Oncol 12:1058, 1994
30. Henry D, Abels R, Larholt K: Prediction of response to recombinant human erythropoietin (r-HuEPO) therapy in cancer patients. Blood 85:1676, 1995
31. Beck MN, Beck D: Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer. Med Pediatr Oncol 25:17, 1995
32. Porter JC, Leahey A, Polise K, Bunin G, Manno CS: Recombinant human erythropoietin reduces the needs for erythrocyte and platelet transfusions in pediatric patients with sarcoma: A randomized, double-blind, placebo-controlled trial. J Pediatr 129:656, 1996
33. Teicher BA, Kakeji Y, Rice G, Singer J: Lisofylline (LSF) accelerates hematopoietic recovery and enhances tumor response after high dose chemotherapy. Blood 88:346a, 1996 (abstr)